Apramycin

Apramycin
Clinical data
AHFS/Drugs.com International Drug Names
ATCvet code QA07AA92 (WHO) QJ01GB90 (WHO) QJ51GB90 (WHO)
Identifiers
CAS Number 37321-09-8 N
PubChem (CID) 3081545
DrugBank DB04626 YesY
ChemSpider 2339128 YesY
UNII 388K3TR36Z YesY
KEGG D02322 YesY
ChEBI CHEBI:2790 YesY
ChEMBL CHEMBL1230961 N
Chemical and physical data
Formula C21H41N5O11
Molar mass 539.58 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Apramycin (also Nebramycin II) is an aminoglycoside antibiotic used in veterinary medicine. It is produced by Streptomyces tenebrarius.[1]

Spectrum of bacterial susceptibility and resistance

Apramycin can be used to treat bacterial infections in animals caused by Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The following shows susceptibility data on medically significant organisms:

[2]

References

  1. R. Ryden; B. J. Moore (1977). "The in vitro activity of apramycin, a new aminocyditol antibiotic". J Antimicrob Chemother. 3 (6): 609–613. doi:10.1093/jac/3.6.609. PMID 340441.
  2. http://antibiotics.toku-e.com/antimicrobial_1728.html
This article is issued from Wikipedia - version of the 2/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.